Expression and prognostic significance of cyclin B1 and cyclin A in non‐small cell lung cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Histopathology

• Publication date

  2009-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2559.2009.03331.xPMID 19614764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions

  2008cited by this paper
• Cyclin A expression and its diagnostic value in pleomorphic adenoma and carcinoma expleomorphic adenoma of the parotid gland

  2007cited by this paper
• Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma.

  2007cited by this paper
• Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis

  2007cited by this paper
• p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate

  2006cited by this paper
• Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation

  2006cited by this paper
• Prognostic significance of cyclin A in gastric cancer

  2006cited by this paper
• Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients

  2006cited by this paper
• T Cell–Dependent Antibody Responses against Aberrantly Expressed Cyclin B1 Protein in Patients with Cancer and Premalignant Disease

  2005cited by this paper
• Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome

  2005cited by this paper
• The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer.

  2004cited by this paper
• Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients

  2004cited by this paper
• Cyclin A as a Predictive Factor for Chemotherapy Response in Advanced Head and Neck Cancer

  2004cited by this paper
• Prognostic value of cyclin B1 protein expression in colorectal cancer.

  2004cited by this paper
• Cell-cycle checkpoints and cancer

  2004cited by this paper
• Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan.

  2003cited by this paper
• Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node‐negative breast cancer

  2003cited by this paper
• Expression of cyclins E, A, and B, and prognosis in lymph node‐negative breast cancer

  2003cited by this paper
• Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas

  2003cited by this paper
• A novel immunohistochemical method to estimate cell‐cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer

  2003cited by this paper
• Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma

  2002cited by this paper
• Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study

  2002cited by this paper
• Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus.

  2002cited by this paper
• The relationship between cyclin B1 overexpression and lymph node metastasis in human colorectal cancer.

  2002cited by this paper
• Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma.

  2002cited by this paper
• Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53.

  2002cited by this paper
• AJCC Cancer Staging Manual. 6th ed

  2002cited by this paper
• Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue.

  2001cited by this paper
• Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression.

  2001cited by this paper
• Over‐expression of cyclin a is highly associated with early relapse and reduced survival in patients with primary breast carcinomas

  2001cited by this paper
• Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis.

  2001cited by this paper
• Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer.

  2001cited by this paper
• Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.

  2000influential reference
• Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.

  2000cited by this paper
• Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival

  1999cited by this paper
• Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma

  1999cited by this paper
• Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival

  1999cited by this paper
• Mechanisms of G2 arrest in response to overexpression of p53.

  1999cited by this paper
• The prognostic significance of proliferation‐associated nucleolar protein p120 expression in prostate adenocarcinoma

  1999cited by this paper
• Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival.

  1999cited by this paper
• Nuclear export of cyclin B1 and its possible role in the DNA damage‐induced G2 checkpoint

  1998cited by this paper
• Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma.

  1998cited by this paper
• Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas.

  1998cited by this paper
• Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.

  1998cited by this paper
• Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas.

  1997cited by this paper
• Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma.

  1996cited by this paper
• Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

  1995influential reference
• Survival in early-stage non-small cell lung cancer.

  1995cited by this paper

• Elevated origin recognition complex subunit 6 expression promotes non-small cell lung cancer cell growth

  2024cites this paper
• Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy

  2024cites this paper
• Integrated analysis of cell cycle and p53 signaling pathways related genes in breast, colorectal, lung, and pancreatic cancers: implications for prognosis and drug sensitivity for therapeutic potential

  2024cites this paper
• Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation.

  2024cites this paper
• Compound K is a potential clinical anticancer agent in prostate cancer by arresting cell cycle.

  2022cites this paper
• In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC)

  2022cites this paper
• Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19

  2022cites this paper
• Prediction of Genes Involved in Lung Cancer with a Systems Biology Approach Based on Comprehensive Gene Information

  2021cites this paper
• Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis

  2021cites this paper
• High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus

  2021cites this paper
• YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation

  2021cites this paper
• Chemopreventive effects of pterostilbene through p53 and cell cycle in mouse lung of squamous cell carcinoma model

  2021cites this paper
• Atypical cyclins in cancer: New kids on the block?

  2020cites this paper
• Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of Notch, Hedgehog, Wnt, and ErbB signalling

  2020cites this paper
• miR-508-3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7

  2020cites this paper
• Integrated Analysis of lncRNA–Mediated ceRNA Network in Lung Adenocarcinoma

  2020cites this paper
• Degradation of CCNB1 mediated by APC11 through UBA52 ubiquitination promotes cell cycle progression and proliferation of non-small cell lung cancer cells.

  2019cites this paper
• MicroRNA-718 serves a tumor-suppressive role in non-small cell lung cancer by directly targeting CCNB1

  2019cites this paper
• Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis

  2019cites this paper
• miR-190, CDK1, MCM10 and NDC80 predict the prognosis of the patients with lung cancer

  2019cites this paper
• Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers

  2019cites this paper
• PLK 1 during G 2 / M phase in synergistic action with Bora , a known cofactor of Aurora A

  2019cites this paper
• Adaptive Protein Translation by the Integrated Stress Response Maintains the Proliferative and Migratory Capacity of Lung Adenocarcinoma Cells

  2019influential citation
• A squalamine derivative, NV669, as a novel PTP1B inhibitor: in vitro and in vivo effects on pancreatic and hepatic tumor growth

  2019cites this paper
• Clinical significance and biological roles of cyclins in gastric cancer

  2018cites this paper
• An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis.

  2018cites this paper
• Integrated Bioinformatics Analysis for Identificating the Therapeutic Targets of Aspirin in Small Cell Lung Cancer

  2018cites this paper
• Expression of cyclin B1, D1 and K in non‑small cell lung cancer H1299 cells following treatment with sulforaphane.

  2018cites this paper
• Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

  2018cites this paper
• A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancer

  2017cites this paper
• Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors

  2017influential citation
• Cyclin A2 regulates homologous recombination DNA repair and sensitivity to DNA damaging agents and poly(ADP-ribose) polymerase (PARP) inhibitors in human breast cancer cells

  2017cites this paper
• SIFORM: shared informative factor models for integration of multi-platform bioinformatic data

  2016cites this paper
• Identification of informative genes and pathways using an improved penalized support vector machine with a weighting scheme

  2016cites this paper
• Prognostic role of cyclin B1 in solid tumors: a meta-analysis

  2016cites this paper
• PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.

  2015cites this paper
• CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients.

  2015cites this paper
• Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma

  2015cites this paper
• Id-1B, an alternatively spliced isoform of the inhibitor of differentiation-1, impairs cancer cell malignancy through inhibition of proliferation and angiogenesis.

  2014cites this paper
• The role of myoferlin and dysferlin in lung epithelial cell membrane functions and lung cancer

  2014cites this paper
• Eupolyphaga sinensis Walker inhibits human chronic myeloid leukemia cell K562 growth by inducing G2-M phase cell cycle arrest and targeting EGFR signaling pathway and in S180 tumor-bearing mice.

  2014cites this paper
• Cyclin B2 and p53 control proper timing of centrosome separation

  2014cites this paper
• Strong expression of cyclin B2 mRNA correlates with a poor prognosis in patients with non-small cell lung cancer

  2014cites this paper
• Cell cycle inhibitors for the treatment of NSCLC

  2014cites this paper
• Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer

  2013cites this paper
• Challenges and Opportunities for Cancer Vaccines in the Current NSCLC Clinical Scenario

  2013cites this paper
• Synergistic Effect of Bcl-2 and Cyclin A2 on Adverse Recurrence-Free Survival in Stage I Non-small Cell Lung Cancer

  2013cites this paper
• Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition.

  2013cites this paper
• Downregulation and growth inhibitory role of FHL1 in lung cancer

  2012cites this paper
• Digitoxin and its analogs as novel cancer therapeutics

  2012cites this paper
• Prognostic and Predictive Value of Cell Cycle Deregulation in Non-Small-Cell Lung Cancer

  2012cites this paper
• Synergistic Effect of Bcl-2 and Cyclin A2 on Adverse Recurrence-Free Survival in Stage I Non-small Cell Lung Cancer

  2012cites this paper
• Oestrogen receptor β in NSCLC – prevalence, proliferative influence, prognostic impact and smoking

  2012cites this paper
• Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.

  2011cites this paper
• Role of cell cycle regulators in lung carcinogenesis

  2010cites this paper
• Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration.

  2010cites this paper